| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
JVC Stock Overview
Japan Vietnam Medical Investment and Development Joint Stock Company engages in the supply and installation of medical equipment and devices.
Japan Vietnam Medical Investment and Development Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫5,790.00 |
| 52 Week High | ₫14,200.00 |
| 52 Week Low | ₫4,000.00 |
| Beta | 0 |
| 1 Month Change | 20.37% |
| 3 Month Change | -12.27% |
| 1 Year Change | 35.28% |
| 3 Year Change | 118.49% |
| 5 Year Change | 42.96% |
| Change since IPO | -67.51% |
Recent News & Updates
Shareholder Returns
| JVC | VN Healthcare | VN Market | |
|---|---|---|---|
| 7D | 6.8% | 0.7% | 3.7% |
| 1Y | 35.3% | -20.5% | -7.0% |
Return vs Industry: JVC exceeded the VN Healthcare industry which returned -20.5% over the past year.
Return vs Market: JVC exceeded the VN Market which returned -7% over the past year.
Price Volatility
| JVC volatility | |
|---|---|
| JVC Average Weekly Movement | 9.2% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in VN Market | 10.0% |
| 10% least volatile stocks in VN Market | 4.2% |
Stable Share Price: JVC is more volatile than 75% of VN stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: JVC's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of VN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Chung Le | https://www.ytevietnhat.com.vn |
Japan Vietnam Medical Investment and Development Joint Stock Company engages in the supply and installation of medical equipment and devices. It distributes medical equipment and consumables. It serves hospitals, health centers, and clinics.
Japan Vietnam Medical Investment and Development Fundamentals Summary
| JVC fundamental statistics | |
|---|---|
| Market Cap | ₫651.38b |
| Earnings (TTM) | -₫31.69b |
| Revenue (TTM) | ₫499.43b |
0.0x
P/S Ratio0.0x
P/E RatioIs JVC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JVC income statement (TTM) | |
|---|---|
| Revenue | ₫499.43b |
| Cost of Revenue | ₫405.45b |
| Gross Profit | ₫93.98b |
| Other Expenses | ₫125.68b |
| Earnings | -₫31.69b |
Last Reported Earnings
Mar 31, 2017
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did JVC perform over the long term?
See historical performance and comparisonValuation
Is JVC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for JVC?
Other financial metrics that can be useful for relative valuation.
| What is JVC's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | ₫651.38b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does JVC's PB Ratio compare to its peers?
| JVC PB Ratio vs Peers |
|---|
| Company | PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 9.7x | ||
INDIES Indies Pharma Jamaica | 4x | n/a | JA$4.2b |
DNM DANAMECO Medical | 0.8x | n/a | ₫131.3b |
3118 Level Biotechnology | 1.6x | n/a | NT$869.7m |
YIACO YIACO Medical Company K.S.C.P | 32.3x | n/a | د.ك7.7m |
JVC Japan Vietnam Medical Investment and Development | n/a | n/a | ₫651.4b |
Price-To-Book vs Peers: Insufficient data to calculate JVC's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Earnings Ratio vs Industry
How does JVC's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Book vs Industry: Insufficient data to calculate JVC's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is JVC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | n/a |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate JVC's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of JVC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate JVC's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate JVC's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
- Take a look at our analysis of JVC's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
Future Growth
How is Japan Vietnam Medical Investment and Development forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
17.8%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Japan Vietnam Medical Investment and Development has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Take a look at our analysis of JVC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
Past Performance
How has Japan Vietnam Medical Investment and Development performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
15.3%
Historical Healthcare annual earnings growth
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Japan Vietnam Medical Investment and Development has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Discover strong past performing companies
- When a company lacks a financial track record, its management’s track record becomes important. Corporate governance also plays an important role in a young business as board members are seen as highly-experienced leaders to help steer the company into the future. Take a look at Japan Vietnam Medical Investment and Development's management and board experience and expertise to assess their ability to deliver on their strategic promises.
Financial Health
How is Japan Vietnam Medical Investment and Development's financial position?
Financial Health Score
0/6Financial Health Score 0/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
In this section we usually analyse Japan Vietnam Medical Investment and Development's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Japan Vietnam Medical Investment and Development has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Discover healthy companies
- Take a look at our analysis of JVC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Japan Vietnam Medical Investment and Development's financial data was last updated here.
Dividend
What is Japan Vietnam Medical Investment and Development current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate JVC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate JVC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if JVC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if JVC's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: JVC is not paying a notable dividend for the VN market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as JVC has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
2.4yrs
Average management tenure
CEO
Chung Le
1.08yrs
Tenure
Mr. Chung Minh Le is Chief Executive Officer of Japan Vietnam Medical Investment and Development Joint Stock Company (Formally known as Japan Vietnam Medical Instrument Joint Stock Company) from July 13, 2...
Leadership Team
Experienced Management: JVC's management team is considered experienced (2.4 years average tenure).
Board Members
Experienced Board: JVC's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Japan Vietnam Medical Investment and Development Joint Stock Company's employee growth, exchange listings and data sources
Key Information
- Name: Japan Vietnam Medical Investment and Development Joint Stock Company
- Ticker: JVC
- Exchange: HOSE
- Founded: 2001
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: ₫651.376b
- Shares outstanding: 112.50m
- Website: https://www.ytevietnhat.com.vn
Location
- Japan Vietnam Medical Investment and Development Joint Stock Company
- Icon 4 building
- 24th Floor
- Hanoi
- Vietnam
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/08 00:00 |
| End of Day Share Price | 2022/08/08 00:00 |
| Earnings | 2017/03/31 |
| Annual Earnings | 2017/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.